Abstract
GVHD is a significant cause of morbidity and mortality following allogeneic peripheral blood stem cell transplantation (AlloPBSC). CD34+ cell selection could reduce GVHD by negative selection of T cells. In an attempt to reduce the T cell content of alloPBSC we carried out a trial in which 11 patients with hematologic malignancies received alloPBSC from HLA-matched siblings following density gradient separation using an isotonic colloidal silica solution (BDS 60; Dendreon Corporation). Cyclosporine and methylprednisone were used for GVHD prophylaxis. The mean yield of CD34+ cells was 69 ± 15.6% with a purity of 2.9 ± 1.7%. The mean number of CD3+ cells infused was 1.0 ± 1.2 × 107/kg, representing a 1.3 log depletion. A high risk of acute GVHD was observed: grade II–IV in 7/11 (64%) and grade III–IV GVHD in 5/11 (45%) patients. Nine of the 11 (82%) patients died with a median survival of 68 days. Cytokine expression in PBSC was compared pre and post processing. Interferon-gamma was detected only following density gradient separation while IL-8 expression increased 3- to 6-fold post processing. Therefore, processing with this device may augment production of pro-inflammatory cytokines. Bone Marrow Transplantation (2000) 25, 1223–1228.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Brown R, Adkins D, Khoury H et al. Long term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: graft-versus-host disease and transplant-related mortality J Clin Oncol 1999 17: 806–812
Storek J, Gooley T, Siadak M et al. Allogeneic peripheral blood stem cell transplantation may be associated with high risk of chronic graft-versus-host disease Blood 1997 12: 4705–4709
Verdonck L, Dekker A, de Gast GC et al. Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft Blood 1994 83: 3090–3096
Przepiorka D, Van Vlasselaer P, Huynh L et al. Rapid debulking and CD34 enrichment of filgrastim-mobilized peripheral blood stem cells by semiautomated density gradient centrifugation in a closed system J Hematother 1996 5: 497–502
Laport GF, Zimmerman TM, Grinblatt DL et al. Final update: a phase I/II trial of the ACT CD 34+ enrichment kit to enrich mobilized peripheral blood progenitor cells for breast cancer patients receiving high dose chemotherapy Blood 1998 92: (Suppl. 1) 312b (Abstr. 4344)
Brown R, Adkins D, Goodnough L et al. Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies J Clin Oncol 1997 15: 3067–3074
Roscoe RA, Rybka WB, Winkelstein A et al. Enumeration of CD34+ hematopoietic stem cells for reconstitution following myeloablative therapy Cytometry 1994 16: 74–79
Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors Transplantation 1974 18: 295–304
Shulman H, Sullivan K, Weiden P et al. Chronic graft-versus-host syndrome in man Am J Med 1980 69: 204–217
Hale G, Waldmann H . Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection Bone Marrow Transplant 1996 17: 305–308
Fischer A, Durandy A, de Villartay J et al. HLA-haploidentical bone marrow transplantation for severe combined immunodeficiency using E rosette fractionation and cyclosporine Blood 1986 67: 444–449
Wagner J, Donnenberg A, Noga S et al. Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: results of a phase I clinical trial Blood 1988 72: 1168–1176
Reisner Y, Kapoor N, Kirkpatrick D et al. Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatibility parental marrow cells fractionated by soybean agglutinin and sheep red blood cells Blood 1983 61: 341–348
O'Reilly R, Collins N, Brochstein J et al. Soyabean lectin agglutination and E rosette depletion for removal of T cells from HLA identical marrow grafts: results in 60 consecutive patients transplanted for hematopoietic malignancy. In: Hagenbeck A, Lowenberg B (eds). Minimal Residual Disease in Acute Leukemia Martins Nijhoff: Zoetermeer, The Netherlands 1986; pp. 337–433
Urbano-Ispizua A, Solano C, Brunet S et al. Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique Bone Marrow Transplant 1998 22: 519–525
Finke J, Brugger W, Bertz H et al. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors Bone Marrow Transplant 1996 18: 1081–1086
Garcia-Conde J, Martin-Gaitero M, Arbona C et al. High frequency of chronic graft versus host disease (GVHD) associated with unmodified allogeneic peripheral blood progenitor cell transplantation (Allo-PBPCT). Preliminary results of allogeneic CD34+ selected cell PBPCT Blood 1996 88: (Suppl. 1) 261a (Abstr. 1031)
Bensinger W, Buckner C, Shannon-Dorcy K et al. Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy Blood 1996 88: 4132–4138
Link H, Arseniev L, Bahre O et al. Transplantation of allogeneic CD34+ blood cells Blood 1996 87: 4903–4909
Bensinger W, Rowley S, Appelbaum F et al. CD34 selected allogeneic peripheral blood stem cell transplantation in older patients with advanced hematologic malignancies Blood 1995 86: (Suppl. 1) 97a (Abstr. 376)
Bertolini F, Thomas T, Battaglia M et al. A new ‘two step’ procedure for 4.5 log depletion of T and B cells in allogeneic transplantation and of neoplastic cells in autologous transplantation Bone Marrow Transplant 1997 19: 615–619
Clarke E, Potter MN, Hale G et al. Double T cell depletion of bone marrow using sequential positive and negative cell immunoaffinity or CD34+ cells and progenitor cell recoveries Bone Marrow Transplant 1998 22: 117–124
Read EJ, Vigue FE, Carter CS et al. Clinical trial of automated 2-step T-cell depletion of peripheral blood progenitor cells for matched related allogeneic transplant Blood 1998 92: (Suppl. 1) 446a (Abstr. 1846)
Hertenstein B, Arseniev L, Novotny J et al. Transplantation of CD34+ selected blood cells for HLA-identical sibling donors – Impact on CMV-infection and relapse Blood 1997 90: (Suppl. 1) 103a (Abstr. 453)
Troutt A, Kelso A . Enumeration of lymphokine mRNA-containing cells in vivo in a murine graft-versus-host reaction using the PCR Proc Natl Acad Sci USA 1992 89: 5276–5280
Kelso A . Frequency analysis of lymphokine-secreting CD4+ and CD8+ T cells activated in a graft-versus-host reaction J Immunol 1990 145: 2167–2176
Smith S, Terminelli C, Kenworthy-Bott L et al. A study of cytokine production in acute graft-vs-host disease Cell Immunol 1991 134: 336–348
Velardi A, Varese P, Terenzi A et al. Lymphokine production by T-cell clones after human bone marrow transplantation Blood 1989 74: 1665–1672
Uguccioni M, Meliconi R, Nesci S et al. Elevated interleukin-8 serum concentrations in beta-thalassemia and graft-versus-host disease Blood 1993 81: 2252–2256
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vij, R., Brown, R., Shenoy, S. et al. Allogeneic peripheral blood stem cell transplantation following CD34+ enrichment by density gradient separation. Bone Marrow Transplant 25, 1223–1228 (2000). https://doi.org/10.1038/sj.bmt.1702427
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702427